Skip to main content
Premium Trial:

Request an Annual Quote

Siemens Healthcare Establishes MDx Research Facility in Germany

NEW YORK (GenomeWeb News) – Siemens Healthcare this week said that it has established a new research lab focused on molecular diagnostics in Cologne, Germany.
 
The medical imaging and diagnostics giant said that the initial focus of the research labs will be on breast cancer diagnostics. It said that it would employ biochips in developing the tests, but did not say whether the chips were developed internally or are based on another company’s technology.
 
Siemens noted that it currently has 40 employees in Cologne developing molecular diagnostic tests for cancer.
 
“Viewed from the perspective of Siemens, a medicine that is more strongly based on molecular medical and knowledge-based techniques will be able to make important long-term contributions toward improving the quality and increasing the efficiency of healthcare,” Donal Quinn, CEO of the Diagnostics Division of Siemens Healthcare, said in a statement.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.